Nitric oxide synthase in experimental autoimmune myocarditis dysfunction

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 11, 1998, Pages 2467-2474

  Goren, Nora ^a   Pérez Leiros, Claudia ^a   Sterin Borda, Leonor ^a   Borda, Enri ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Autoimmunity; Heart contractility; IFN ; iNOS; Myocarditis; Protein kinase C

Indexed keywords

ARGININE; CITRULLINE; DEXAMETHASONE; GAMMA INTERFERON; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; STAUROSPORINE; TRIFLUOPERAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART ATRIUM; HEART DISEASE; HEART MUSCLE CONTRACTILITY; IMMUNOBLOTTING; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032213820     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0809     Document Type: Article

References (35)

1. BACHMAIER K, NEU N, PUMMERER C, DUNCAN GS, MAK TW, MATSUYAMA T, PENNINGER JM, 1997. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 96: 585-591.
2. BALLIGAN JL, KELLY RA, MARSDEN PA, SMITH TW, MICHEL T, 1993. Control of cardiac muscle cells function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90: 347-351.
3. BALLIGAN JL, UNGUREANU-LONGROIS D, SIMMONS WW, PIMENTAL D, MALINSKI TA, KAPTURCZAK M, TAHA Z, LOWENSTEIN CJ, DAVIDOFF AJ, KELLY RA, SMITH TW, MICHEL T, 1994. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem269: 27580-27588.
4. BALTRONS MA, AGULLO L, GARCIA A, 1995. Dexametasone up-regulates a constitutive nitric oxide synthase in cerebellar astrocytes but not in granule cells in culture. J Neurochem 64: 447-450.
5. BILLIAR TR, CURRAN RD, STUER DJ, WEST MA, BENTZ BI, SIMMONS RL, 1989. An L-arginine dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 169: 1467-1472.
6. BORDA ES, PEREZ LEIROS C, STERIN-BORDA L, BRACCO MM, 1991. Cholinergic response of isolated rat atria to recombinant rat interferon gamma. J Neuroimmunol 32: 53-59.
7. BREDT DS, SNYDER SH, 1989. Nitric oxide mediates glutamate-linked enhancement of cyclic GMP levels in the cerebellum. Proc Natl Acad Sci USA 86: 9030-9033.
8. DE BELDER AJ, RADOMSKI MW, WHY HJF, RICHARDSON PJ, BUCKNALL CA, SALAS E, MARTIN JF, MONCADA S, 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85.
9. DUONG TT, LOUIS JS, GILBERT JJ, FINKELMAN FD, STREJAN GH, 1992. Effect of anti-interferon gamma and anti-interleukin two monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 36: 105-115.
10. FARASI WS, NAGEL AA, VERDRIES KA, VINCENT LA, HONG XU L, NICHOLS LE, LABASI JM, SALTER ED, PETTIPHER ER, 1996. 2-amino-4-methylpyridine as a potent inhibitor of inducible NOS activity in vitro and in vivo. Br J Pharmacol 119: 1101-1108.
11. FINKEL MS, ODDIS CV, JACOB TD, WATKINS SC, HATTLER BG, SIMMONS RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
12. GOIN JC, PEREZ LEIROS C, BORDA ES, STERIN-BORDA L, 1994. Modification of cholinergic-mediated cellular transmembrane signals by the interaction of human chagasic IgG with cardiac muscarinic receptors. Neurolimmunomodulation 1: 284-291.
13. GOIN JC, PEREZ LEIROS C, BORDA ES, STERIN-BORDA L, 1997. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptors. Functional and pathological implication. FASEB J 10: 77-83.
14. HAN X, SHIMONI Y, GILES WR, 1994. An obligatory role of nitric oxide autonomic control of mammalian heart rate. J Physiol 476: 309-314.
15. ISHIYAMA S, HIROE M, NISHIKAWA T, ABE S, SHIMOJO T, ITO H, OZASA S, YAMAKAWA K, MATSUZAKI M, MOHAMMED MU, NAKAZAWA H, KASAJIMA T, MARUMO F, 1997. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 95: 489-496.
16. LOWENSTEIN CJ, HILL SL, LAFOND-WALKER A, WU J, LANDAVERE M, ROSE NR, HERSKOWITZ A, 1996. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97: 1837-1843.
17. MASINI E, GAMBASSI F, DI BELIO MG, MUGNAI L, RASPANTI S, MANNAIONI PF, 1994. Nitric oxide modulates cardiac and mast cell anaphylaxis. Agents Actions 41: C89-C90.
18. NAVA E, PALMER RMJ, MONCADA S, 1991. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338: 1555-1557.
19. OGNIBENE FP, PARKER MM, NATANSON C, SHELHAMER JH, PARRILLO JE, 1988. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 93: 903-910.
20. PEREZ LEIROS C, STERIN-BORDA L, COSSIO PM, BUSTOUABAB O, BORDA ES, 1986. Potential role of mononuclear cell infiltration on the autoimmune myocardial dysfunction. Clin Exp Immunol 63: 648-665.
21. PEREZ LEIROS C, STERIN-BORDA L, BORDA ES, 1988. Lymphocytes infiltration induces dysfunction in autoimmune myocarditis: role of SRS-A. J Mol Cell Cardiol 20: 149-158.
22. PEREZ LEIROS C, STERIN-BORDA L, BORDA ES, 1989. Beta adrenergic cardiac antibody in autoimmune myocarditis. Autoimmunity 2: 223-234.
23. PEREZ LEIROS C, STERIN-BORDA L, GOREN N, BORDA ES, 1995. Experimental autoimmune myocarditis: a suitable model to study neuroimmune crosstalk. Acta Physiol Pharm Therap Latinoam 45: 201-212.
24. PEREZ LEIROS C, GOREN N, STERIN-BORDA L, BORDA ES, 1997. Myocardial dysfunction in an experimental model of autoimmune myocarditis: role of interferon gamma. Neuroimmunemodulation 4: 91-97.
25. PETRAY P, ROTTENBERG ME, GRINSTEIN S, ÖRN A, 1994. Release of nitric oxide during the experimental infection with T. cruzi. Parasite Immunol 16: 193-199.
26. ROSE NR, WOLFGRAM LJ, HERESKOWITZ A, BEISEL KW, 1988. Post-infectious autoimmunity: two distinct phases of coxsackie virus B3-induced myocarditis. In: Schwartz RS and Rose NR (Eds), Autoimmunity: Experimental and Clinical Aspects. New York: New York Academy of Sciences, 146-156.
27. STERIN-BORDA L, VILA ECHAGÚE A, PEREZ LEIROS C, GENARO AM, BORDA ES, 1995. Endogenous nitric oxide signaling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br J Pharmacol 115: 1525-1531.
28. STERIN-BORDA L, PEREZ LEIROS C, BORDA ES, BRACCO MM, 1996. Effects of IL-2 on the myocardium. Participation of the sympathetic system. J Mol Cell Cardiol 28: 2457-2465.
29. STERIN-BORDA L, PEREZ LEIROS C, GOIN JC, CREMASCHI G, GENARO AM, VILA ECHAGÚE A, BORDA ES, 1997. Participation of nitric oxide signaling system in the cardiac muscarinic cholinergic effect of human chagasic IgG. J Mol Cell Cardiol 29: 1851-1865.
30. STUEHR DJ, GRIFFITH OW, 1992. Mammalian nitric oxide synthases. Adv Enzymol Relat Area Mol Biol 65: 287-346.
31. THELEN KI, DEMBINSKA-KIÉC A, PALLAPIES D, 1992. Effect of 3-morpholinosydnonimine (SIN-1) and n-nitro-L-arginine (NNA) on isolated perfused anaphylactic guinea pig hearts. Naunyn-Schiedeberg's Arch Pharmacol 345: 93-99.
32. THOENES M, FÓRSTERMANN U, ROSS TRACEY W, BLESSE NM, NUSSLER AK, SCHOLZ H, STEIN B, 1996. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 28: 165-169.
33. UNGUREANU-LONGROIS D, BALLIGAND JL, KELLY RA, SMITH TW, 1995. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155-167.
34. WANG WZ, MATSUMORI A, YAMADA T, SHIOI T, OKADA I, MATSUI S, SATO Y, SUSUKI H, SHIOTA K, SASAYAMA S, 1997. Beneficial effects of amlopidine in a murine model of congestive heart failure induced by viral myocarditis. Circulation 95: 245-251.
35. WINLAW DS, SMYTHE GA, KEOGH AM, SCHYVENS CG, SPRATT PM, MACDONALD PS, 1994. Increased nitric oxide production in heart failure. Lancet 344: 373-374.